SCHEMBL19788095

SCHEMBL19788095

CCOC(=O)C(C)(CCOCCO)C[C@@H](Cc1ccc(-c2cccc(Cl)c2)cc1)NC(=O)c1c[nH]nn1

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MME P08473 13/20 0.46
MMEL1 Q495T6 8/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21351429 0.96 MME (0.45) MMEMMEL1
SCHEMBL24350783 0.96 MME (0.45) MMEMMEL1
SCHEMBL19688094 0.94 MME (0.47) MMEMMEL1
SCHEMBL15472667 0.94 MME (0.47) MMEMMEL1
SCHEMBL19688095 0.89 MME (0.46) MMEMMEL1
SCHEMBL15472674 0.89 MME (0.46) MMEMMEL1
SCHEMBL19788097 0.86 MME (0.53) MMEMMEL1
SCHEMBL15472669 0.86 MME (0.53) MMEMMEL1
SCHEMBL19687911 0.85 MME (0.51) MMEMMEL1
SCHEMBL24351369 0.85 MME (0.51) MMEMMEL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9873685-B2 Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (US) 2018-01-23 US disclosed